Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Pharmala Biotech Holdings Inc C.MDMA

Alternate Symbol(s):  MDXXF

PharmAla Biotech Holdings Inc. is a Canada-based biotechnology company. The Company is focused on the development, manufacture and sales of methylenedioxy methamphetamine (MDMA) and methylenedioxy phenethylamines (MDXX) class molecules in service to the burgeoning clinical research community and growing commercial use cases in select jurisdictions. The Company has three primary business lines: the manufacture of MDMA and MDXX class molecules for sale to clinical researchers in both the commercial and academic sphere, the research and development of novel MDXX class compounds which offer unique benefits above and beyond known substances, and the development of novel delivery mechanisms for MDMA and MDXX class compounds. Its research and development unit has completed proof-of-concept research into several IP families, including ALA-002, its lead drug candidate. It works with laboratories across Canada to develop novel processes for the supply of LaNeo MDMA and other MDXX substances.


CSE:MDMA - Post by User

Comment by Flagshipzillaon May 07, 2023 3:40pm
56 Views
Post# 35435455

RE:RE:RE:MDMA.CN: Extend that timeline and don't mind the shorts

RE:RE:RE:MDMA.CN: Extend that timeline and don't mind the shortsIn the same space or do you mean industry....  You should look at other companies in the same industry.  One pop and down down down after that.  Like NUMI or TRIP or MMED.  For the past 2 years their SP's have been losing ground.  The CSE index is in the crapper.  No one is financing that industry anymore.  MDMA only has around 500,000 left in cash and the co Panay stated it could only raise 620,000 if every warrant or option available were to be exercised.   OST people invested without doing any research due to hype and spam.  So shorters can easily spook investors when they realize how weak MDMA really is.  Down 30% in one week.  Smart investors sell only for a 15% drop.  Monday will be pretty bad.  
<< Previous
Bullboard Posts
Next >>